Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women

被引：2
|
作者：
Draper, MW [1 ]
Plouffe, L [1 ]
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
OBSTETRICS AND GYNECOLOGY | 2005年 / 106卷 / 05期
关键词：
D O I：
10.1097/01.AOG.0000186081.62399.61
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1110 / 1111
页数：2
相关论文
共 50 条
  • [41] Raloxifene: a selective estrogen receptor modulator for reducing the risk of invasive breast cancer in postmenopausal women
    Vogel, Victor G.
    WOMENS HEALTH, 2007, 3 (02) : 139 - 153
  • [42] SAFETY AND EFFICACY OF OSPEMIFENE, A SELECTIVE ESTROGEN RECEPTOR MODULATOR, FOR TREATEMENT OF POSTMENOPAUSAL WOMEN WITH VULVOVAGINAL ATROPHY
    Portman, David
    Simon, James
    Goldstein, Steven
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 165 - 165
  • [43] The combination of a novel selective estrogen receptor modulator with an estrogen protects the mammary gland and uterus in a rodent model:: The future of postmenopausal women's health?
    Labrie, F
    El-Alfy, M
    Berger, L
    Labrie, C
    Martel, C
    Bélanger, A
    Candas, B
    Pelletier, G
    ENDOCRINOLOGY, 2003, 144 (11) : 4700 - 4706
  • [44] Effects of bazedoxifene (tse-424), a novel tissue selective estrogen receptor modulator (SERM), on biochemical markers of bone metabolism in a Chinese population
    Xu, L
    Liu, JL
    Lin, JF
    Wang, SY
    Wu, YY
    Huang, QR
    Pol, B
    Paul, K
    Jamie, T
    Chen, XX
    Julien, C
    Jean-Yves, R
    Ginger, C
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S97 - S98
  • [45] SELECTIVE ESTROGEN RECEPTOR MODULATORS: RALOXIFENE AND BAZEDOXIFENE
    Kaufman, J. -M.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S139 - S140
  • [46] Effect of HMR 3339, a novel selective estrogen receptor modulator, on C-reactive protein levels in healthy postmenopausal women
    Vogelvang, TE
    Mijatovic, V
    Kenemans, P
    Schalkwijk, CG
    van der Mooren, MJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (09): : 1205 - 1208
  • [47] Erratum to Raloxifene: the first selective estrogen receptor modulator for postmenopausal osteoporosis
    Drugs & Therapy Perspectives, 1999, 13 (3) : 5 - 5
  • [48] Lasofoxifene: Selective Estrogen Receptor Modulator for the Prevention and Treatment of Postmenopausal Osteoporosis
    Peterson, Gregory M.
    Naunton, Mark
    Tichelaar, Lisette K.
    Gennari, Luigi
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (04) : 499 - 509
  • [49] Lasofoxifene: A next generation selective estrogen receptor modulator (SERM) for the prevention of bone loss in postmenopausal women
    Bolognese, MA
    Weiss, SR
    Ettinger, MP
    Moffett, AH
    Lee, A
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S11 - S11
  • [50] Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia
    Kulkarni, Jayashri
    Gurvich, Caroline
    Lee, Stuart J.
    Gilbert, Heather
    Gavrilidis, Emmy
    de Castella, Anthony
    Berk, Michael
    Dodd, Seetal
    Fitzgerald, Paul B.
    Davis, Susan R.
    PSYCHONEUROENDOCRINOLOGY, 2010, 35 (08) : 1142 - 1147
12345